导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 54.90% | 29/1050 |
| 近一周 | -1.54% | 239/1104 |
| 近一月 | -7.68% | 890/1102 |
| 近一季 | -3.78% | 384/1092 |
| 近半年 | 36.84% | 46/1070 |
| 近一年 | 62.15% | 37/1018 |
| 近两年 | 150.65% | 100/926 |
| 近三年 | 99.10% | 92/834 |
| 成立以来 | 110.10% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.90% 147/1070 |
105.55% 26/1101 |
- - |
- - |
| 2025 | 29.07% 487/1065 |
2.36% 615/1014 |
0.14% 670/1038 |
28.56% 384/1050 |
-2.06% 557/1065 |
| 2024 | 7.63% 343/1011 |
-3.67% 512/960 |
3.42% 146/983 |
6.09% 855/991 |
1.84% 244/1011 |
| 2023 | -21.69% 708/952 |
4.87% 339/880 |
-9.39% 748/895 |
-10.86% 616/915 |
-7.54% 730/952 |
| 2022 | -14.57% 162/867 |
-20.53% 546/773 |
11.59% 205/806 |
-9.60% 221/845 |
6.56% 146/867 |
| 2021 | 13.14% 205/740 |
-3.12% 274/580 |
20.41% 158/659 |
-10.34% 519/704 |
8.18% 120/740 |
| 2020 | 52.29% 229/554 |
0.60% 150/419 |
23.07% 224/466 |
9.55% 260/517 |
12.28% 281/554 |
| 2019 | 55.78% 105/410 |
33.60% 192/1149 |
-6.34% 801/1231 |
8.70% 134/390 |
14.53% 61/410 |
| 2018 | -27.06% 178/349 |
- - |
- - |
- - |
-9.05% 214/1080 |
| 2017 | 14.86% 110/285 |
- - |
- - |
- - |
- - |
| 2016 | -18.23% 108/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 嘉实企业变革股票 VS. 东吴新产业精选股票A(580008) |